Coty Inc.: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 10, 2021 and accepted by EDGAR at May 10, 2021, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $1.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-07-01 to 2021-03-31 | $3.57bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-01-01 to 2021-03-31 | $391.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-07-01 to 2021-03-31 | $1.44bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-01-01 to 2021-03-31 | $636.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-07-01 to 2021-03-31 | $2.13bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2021-01-01 to 2021-03-31 | $545.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-07-01 to 2021-03-31 | $1.77bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-01-01 to 2021-03-31 | −$1.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-07-01 to 2021-03-31 | −$50.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-01-01 to 2021-03-31 | $51.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-07-01 to 2021-03-31 | $171.3m | us-gaap:InterestExpense |
| Income tax | 3 months2021-01-01 to 2021-03-31 | −$19.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-07-01 to 2021-03-31 | −$304.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-01 to 2021-03-31 | $15.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-07-01 to 2021-03-31 | −$15.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-01 to 2021-03-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-07-01 to 2021-03-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-01 to 2021-03-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-07-01 to 2021-03-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-01 to 2021-03-31 | 765,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-07-01 to 2021-03-31 | 932,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-07-01 to 2021-03-31 | $286.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-07-01 to 2021-03-31 | $143.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2020-07-01 to 2021-03-31 | $1.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2020-07-01 to 2021-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-03-31 | $315.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $1.82bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $13.62bn | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $2.57bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $9.33bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-03-31 | $5.18bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-03-31 | $193.7m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2021-03-31 | $500.0k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-03-31 | $2.96bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-21-000041. Last ingested by Listed: Nov 11, 2026, 03:30 ET. Listed shows no prices and gives no investment advice.